Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.
Takamatsu H, Matsuda T, Mizuno S, Takahashi T, Fuchida SI, Hanamura I, Kataoka K, Tsukada N, Matsumoto M, Hangaishi A, Doki N, Uchida N, Sawa M, Maruyama Y, Kurahashi S, Nagafuji K, Harazaki Y, Kako S, Iida S, Ichinohe T, Kanda Y, Atsuta Y, Sunami K; Multiple Myeloma Working Group in the Japanese Society for Transplantation and Cellular Therapy. Takamatsu H, et al. Among authors: iida s. Haematologica. 2023 Dec 1;108(12):3399-3408. doi: 10.3324/haematol.2023.283202. Haematologica. 2023. PMID: 37470160 Free PMC article.
[The molecular mechanisms of myelomagenesis].
Hanamura I, Iida S. Hanamura I, et al. Among authors: iida s. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:203-14. Nihon Rinsho. 2007. PMID: 17474414 Review. Japanese. No abstract available.
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma.
Inagaki A, Tajima E, Uranishi M, Totani H, Asao Y, Ogura H, Masaki A, Yoshida T, Mori F, Ito A, Yano H, Ri M, Kayukawa S, Kataoka T, Kusumoto S, Ishida T, Hayami Y, Hanamura I, Komatsu H, Inagaki H, Matsuda Y, Ueda R, Iida S. Inagaki A, et al. Among authors: iida s. Leuk Res. 2013 Dec;37(12):1648-55. doi: 10.1016/j.leukres.2013.09.026. Epub 2013 Oct 18. Leuk Res. 2013. PMID: 24210217
Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era.
Takamatsu H, Honda S, Miyamoto T, Yokoyama K, Hagiwara S, Ito T, Tomita N, Iida S, Iwasaki T, Sakamaki H, Suzuki R, Sunami K. Takamatsu H, et al. Among authors: iida s. Cancer Sci. 2015 Feb;106(2):179-85. doi: 10.1111/cas.12594. Epub 2015 Feb 6. Cancer Sci. 2015. PMID: 25530023 Free PMC article.
1,663 results